Security key
15673T100
Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC)
CUSIP: 15673T100
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 180,747,818
- Total 13F shares
- 22,628,192
- Share change
- -6,936,251
- Total reported value
- $12,642,486
- Price per share
- $0.56
- Number of holders
- 64
- Value change
- -$3,582,180
- Number of buys
- 36
- Number of sells
- 45
Report period
Q2 2025
Institutions
64
Top holders
10
IPSC full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Century Therapeutics, Inc. SEC filings
Century Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 15673T100
Recent filing periods:
Top shareholders of IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAYER AKTIENGESELLSCHAFT |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
12,675,838
|
$18,886,999 | — | 22 Jun 2021 | |
| Versant Venture Capital VI, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
12,166,109
|
$18,127,503 | — | 09 Aug 2022 | |
| FUJIFILM Cellular Dynamics, Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
6,955,207
|
$10,363,258 | — | 22 Jun 2021 | |
| Hyam Levitsky |
3/4/5
|
President of R&D |
—
mixed-class rows
|
706,544
mixed-class rows
|
$2,880,972 | — | 07 Mar 2024 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
3%
|
5,410,361
|
$2,575,332 | — | 31 Mar 2025 | |
| Casdin Capital, LLC |
13D/G
13F
|
Company |
3.7%
|
3,212,316
|
$1,702,527 | $0 | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1.7%
|
3,018,515
|
$1,436,813 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
1.4%
|
2,594,745
|
$1,235,099 | — | 31 Mar 2025 | |
| VR Adviser, LLC |
13F
|
Company |
1.4%
|
2,498,069
|
$1,189,081 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.3%
|
2,377,494
|
$1,131,688 | — | 31 Mar 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.94%
|
1,704,232
|
$811,215 | — | 31 Mar 2025 | |
| Syncona Portfolio Ltd |
13F
|
Company |
0.67%
|
1,213,056
|
$577,415 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.66%
|
1,185,318
|
$564,211 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.54%
|
970,260
|
$461,931 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.5%
|
900,000
|
$428,400 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.47%
|
846,221
|
$402,801 | — | 31 Mar 2025 | |
| Luis Borges |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
256,535
|
$382,237 | — | 03 Apr 2023 | |
| Michael Craig Diem |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
253,533
|
$377,764 | — | 01 Nov 2023 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.26%
|
462,963
|
$220,370 | — | 31 Mar 2025 | |
| Adrienne Farid |
3/4/5
|
Chief Operations Officer |
—
mixed-class rows
|
370,141
mixed-class rows
|
$155,587 | -$343 | 09 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.16%
|
289,601
|
$137,850 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.16%
|
284,229
|
$133,000 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.15%
|
270,820
|
$128,910 | — | 31 Mar 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.13%
|
241,684
|
$115,042 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.1%
|
179,635
|
$85,506 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.09%
|
157,311
|
$74,880 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.07%
|
132,929
|
$63,274 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
120,500
|
$57,358 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.06%
|
111,079
|
$52,874 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.06%
|
105,529
|
$50,232 | — | 31 Mar 2025 | |
| Morgan Conn |
3/4/5
|
Chief Finanical Officer |
—
mixed-class rows
|
99,148
mixed-class rows
|
$48,984 | — | 11 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.05%
|
96,140
|
$46,147 | — | 31 Mar 2025 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.05%
|
90,739
|
$43,192 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.05%
|
86,006
|
$40,939 | — | 31 Mar 2025 | |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC |
13F
|
Company |
0.05%
|
85,083
|
$40,501 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.04%
|
76,900
|
$36,604 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.04%
|
69,490
|
$33,078 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
57,467
|
$27,355 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.03%
|
57,435
|
$27,339 | — | 31 Mar 2025 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.03%
|
52,748
|
$25,108 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.03%
|
47,209
|
$22,471 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.02%
|
43,514
|
$20,713 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
43,273
|
$20,590 | — | 31 Mar 2025 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.02%
|
35,814
|
$17,047 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.02%
|
32,859
|
$15,640 | — | 31 Mar 2025 | |
| HARBOURVEST PARTNERS LLC |
13F
|
Company |
0.02%
|
29,018
|
$13,813 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
28,873
|
$13,744 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
28,838
|
$13,727 | — | 31 Mar 2025 | |
| Parametrica Management Ltd |
13F
|
Company |
0.02%
|
27,840
|
$13,252 | — | 31 Mar 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.02%
|
27,447
|
$13,065 | — | 31 Mar 2025 |
Institutional Holders of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) as of Q2 2025
As of 30 Jun 2025,
Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,628,192 shares.
The largest 10 holders included
Bain Capital Life Sciences Investors, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, DAFNA Capital Management LLC, Casdin Capital, LLC, Syncona Portfolio Ltd, FMR LLC, BlackRock, Inc., TANG CAPITAL MANAGEMENT LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
63
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
69
Q2 2025 holders
64
Holder diff
-5
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.